Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.

Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.

Item
http://www.wikidata.org/entity/Q38883557
MST kinases in development and diseaseHippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerWhole exome and targeted deep sequencing identify genome-wide allelic loss and frequent SETDB1 mutations in malignant pleural mesotheliomas.Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signalingAngiomotin stabilization by tankyrase inhibitors antagonizes constitutive TEAD-dependent transcription and proliferation of human tumor cells with Hippo pathway core component mutationsIntegrated analysis of long non-coding RNAs in human gastric cancer: An in silico study.Targeting YAP in malignant pleural mesothelioma.Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles.Hippo pathway deregulation: implications in the pathogenesis of haematological malignancies.Hypomethylation reduced the aggressive potential of human malignant mesothelioma cells.Drug development against the hippo pathway in mesotheliomaNovel insights into mesothelioma biology and implications for therapy.Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma.Arrhythmogenic cardiomyopathy: Identification of desmosomal gene variations and desmosomal protein expression in variation carriers.Heterogeneous Contributing Factors in MPM Disease Development and Progression: Biological Advances and Clinical Implications.Mutational Profiling of Malignant Mesothelioma Revealed Potential Therapeutic Targets in EGFR and NRAS.Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma.Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.YAP/TAZ Activation as a Target for Treating Metastatic Cancer.Presenilins as Drug Targets for Alzheimer's Disease-Recent Insights from Cell Biology and Electrophysiology as Novel Opportunities in Drug Development.
P2860
Q26787040-D5E55179-0282-485A-84A9-BADD1DE3AE82Q28269498-7B294367-C728-4B60-92E9-33A217505253Q36946792-58ABE85D-BF0E-476D-8AB0-584A8D55E4EDQ37085989-64CE74BE-FB4C-4B4B-8DB6-913773636202Q37301667-FF6DFD43-D1C1-41CF-B92F-0AEACB00897CQ38608109-CA1CD65D-3DEB-4B50-8B79-6DFBFD2D7805Q38704895-40616968-0CDF-4570-8757-4CAAB48B90C0Q38972707-2405E2E2-7096-4D5D-91AF-B458688EF503Q38995148-976EB023-AC65-4EA4-A961-E4638A3EE675Q39179225-D1112E4C-B7F4-4FF7-A556-1139E247AF6EQ39438182-08DF73C9-07CE-445C-B85E-9351F1D65A8DQ39455555-A0036D25-B4BE-443E-B960-B6190E5C1A9BQ40667179-9D9DFA1B-C4BD-49B1-86D7-FC960D93BE6FQ49884493-3AE2BCFC-2C4F-4718-9173-40B9A059204CQ49996923-255BB67B-383D-429C-8AB0-C4EE84622D94Q50137415-FFE5A897-05EF-42E5-A353-B60434DD1C39Q52642770-0C3BC6FB-1083-442C-B5D6-63B354327B9AQ52672884-C41C0241-9CCF-4A2A-9AAF-ADD9FC6CB14EQ54977387-84D9EF84-B766-473E-869D-3C0C667BC01CQ55690547-B45AF1E8-B37D-40B2-A046-BB54150FE46E
P2860

Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing.

Item
http://www.wikidata.org/entity/Q38883557
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Hippo pathway gene mutations i ...... and targeted exon sequencing.
@en
type
label
Hippo pathway gene mutations i ...... and targeted exon sequencing.
@en
prefLabel
Hippo pathway gene mutations i ...... and targeted exon sequencing.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Hippo pathway gene mutations i ...... and targeted exon sequencing.
@en
P2093
P304
P31
P356
10.1097/JTO.0000000000000493
P433
P478
P577
P698